| Financial Year |
March 31 2023 |
| Monetary Funds |
3,351,463,685.62 |
| Held-for-trading Financial Assets |
112,997,808.01 |
| Notes Receivable |
-- |
| Accounts Receivable |
570,713,857.34 |
| Advances to Suppliers |
375,343,333.22 |
| Other Receivables |
198,798,317.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,936,995,812.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
648,195,724.45 |
| Total Current Assets |
14,109,229,918.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
274,389,285.64 |
| Investment Properties |
167,156,898.58 |
| Fixed Assetes |
3,939,811,670.96 |
| Under-construction Projects |
1,252,014,021.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
7,650,109.49 |
| Intangible Assets |
899,870,770.81 |
| R&D expenses |
-- |
| Goodwill |
1,150,960,701.03 |
| Long-Term Deferred and Prepaid Expenses |
36,159,622.69 |
| Deferred Income Tax Assets |
145,683,050.08 |
| Other Non-Current Assets |
84,773,155.35 |
| Sub-Total of Non-Current Assets |
9,842,475,513.20 |
| Total Assets |
23,951,705,431.62 |
| Short-Term Loans |
3,866,922,893.05 |
| Trading Financial liabilities |
28,004,400.00 |
| Notes Payable |
2,755,193,503.63 |
| Accounts Payable |
1,136,493,759.63 |
| Accounts Received In Advance |
2,722,008.99 |
| Employee Compensation Payable |
70,835,171.23 |
| Taxes Payable |
199,446,701.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
417,177,353.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
459,891,529.64 |
| Other Current Liabilities |
149,965,708.02 |
| Sub-Total of Current Liabilities |
9,548,469,635.54 |
| Long-term Loans |
1,682,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
62,400,204.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,778,073.34 |
| Deferred Income Tax Liabilities |
512,693,375.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,388,160,018.91 |
| Total Liabilities |
11,936,629,654.45 |
| Paid-In Capital(Or Share Stock) |
5,369,795,962.00 |
| Capital Surplus |
195,225,519.78 |
| Surplus Reserve |
44,605,029.72 |
| LESS:Treasury Stock |
155,042,572.71 |
| Undistributed Profits |
5,917,707,979.79 |
| Minority Stockholder's Interest |
225,861,453.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,789,214,323.31 |
| Owner's Equity（Stockholder's Equity） |
12,015,075,777.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,951,705,431.62 |
